GLP-1/GLUCAGON RECEPTOR AGONISTS IN THE TREATMENT OF FATTY LIVER DISEASE AND STEATOHEPATITIS

• 收藏
• 分享

专利权人:

SANOFI

发明人:

Aimo KANNT,Maximilian BIELOHUBY,Ralf ELVERT,Michael WAGNER,Martin BOSSART,Torsten HAACK,Stephanie KEIL,Werner SEIZ

申请号：

US16637517

公开号：

US20200216510A1

申请日:

2018.08.08

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present invention relates to the medical use of specific GLP-1/glucagon receptor agonists in the prevention and/or treatment of metabolic liver disease, particularly non-alcoholic fatty liver disease (NAFLD), more particularly non-alcoholic fatty liver (NAFL), non-alcoholic steatohepatitis (NASH) and/or NAFLD-associated liver fibrosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/